» Articles » PMID: 31356773

The Human Uncoupling Proteins 5 and 6 (UCP5/SLC25A14 and UCP6/SLC25A30) Transport Sulfur Oxyanions, Phosphate and Dicarboxylates

Overview
Publisher Elsevier
Date 2019 Jul 30
PMID 31356773
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The human genome encodes 53 members of the solute carrier family 25 (SLC25), also called the mitochondrial carrier family. In this work, two members of this family, UCP5 (BMCP1, brain mitochondrial carrier protein 1 encoded by SLC25A14) and UCP6 (KMCP1, kidney mitochondrial carrier protein 1 encoded by SLC25A30) have been thoroughly characterized biochemically. They were overexpressed in bacteria, purified and reconstituted in phospholipid vesicles. Their transport properties and kinetic parameters demonstrate that UCP5 and UCP6 transport inorganic anions (sulfate, sulfite, thiosulfate and phosphate) and, to a lesser extent, a variety of dicarboxylates (e.g. malonate, malate and citramalate) and, even more so, aspartate and (only UCP5) glutamate and tricarboxylates. Both carriers catalyzed a fast counter-exchange transport and a very low uniport of substrates. Transport was saturable and inhibited by mercurials and other mitochondrial carrier inhibitors at various degrees. The transport affinities of UCP5 and UCP6 were higher for sulfate and thiosulfate than for any other substrate, whereas the specific activity of UCP5 was much higher than that of UCP6. It is proposed that a main physiological role of UCP5 and UCP6 is to catalyze the export of sulfite and thiosulfate (the HS degradation products) from the mitochondria, thereby modulating the level of the important signal molecule HS.

Citing Articles

Exploring the proton transport mechanism of the mitochondrial ADP/ATP carrier: FA-cycling hypothesis and beyond.

Pohl E, Vazdar M, Kreiter J Protein Sci. 2025; 34(3):e70047.

PMID: 39969060 PMC: 11837047. DOI: 10.1002/pro.70047.


The impact of solute carrier proteins on disrupting substance regulation in metabolic disorders: insights and clinical applications.

Du J, Shen M, Chen J, Yan H, Xu Z, Yang X Front Pharmacol. 2025; 15():1510080.

PMID: 39850557 PMC: 11754210. DOI: 10.3389/fphar.2024.1510080.


Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review.

Gao R, Zhou D, Qiu X, Zhang J, Luo D, Yang X Cancer Control. 2024; 31:10732748241287905.

PMID: 39313442 PMC: 11439189. DOI: 10.1177/10732748241287905.


Development and Validation of Diagnostic Models for Transcriptomic Signature Genes for Multiple Tissues in Osteoarthritis.

Gao Q, Ma Y, Shao T, Tao X, Yang X, Li S J Inflamm Res. 2024; 17:5113-5127.

PMID: 39099665 PMC: 11298182. DOI: 10.2147/JIR.S472118.


Toward understanding the cellular control of vertebrate mineralization: The potential role of mitochondria.

Shapiro I, Risbud M, Landis W Bone. 2024; 185:117112.

PMID: 38697384 PMC: 11251007. DOI: 10.1016/j.bone.2024.117112.